⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALVO News
Alvotech Ordinary Shares
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area
globenewswire.com
ALVO
Markaðsleyfi veitt á Evrópska efnahagssvæðinu fyrir AVT03, hliðstæðu Alvotech við líftæknilyfin Prolia og Xgeva
globenewswire.com
ALVO
AMGN
STDA
DRREDDY
Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Alvotech (ALVO)
accessnewswire.com
ALVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
accessnewswire.com
ALVO
Ongoing Investigation: Alvotech (ALVO) May Have Misled Shareholders – Levi & Korsinsky Investigates
accessnewswire.com
ALVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
accessnewswire.com
ALVO
Levi & Korsinsky Investigating Whether Alvotech (ALVO) Misled Investors - Securities Law Violations Possible
accessnewswire.com
ALVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
accessnewswire.com
ALVO
Securities Investigation: Levi & Korsinsky Investigates Alvotech (ALVO) on Behalf of Investors
accessnewswire.com
ALVO
Bronstein, Gewirtz & Grossman, LLC Encourages Alvotech (ALVO) Shareholders to Inquire about Securities Investigation
accessnewswire.com
ALVO